NICE publishes updated guideline on diagnosis and management of epilepsies (CG137)
The MHRA guidance advises valproate must not be used in any woman or girl able to have children unless there is a pregnancy prevention programme (PPP) in place. This is designed to make sure patients are fully aware of the risks and the need to avoid becoming pregnant.
Source:
National Institute for Health and Care Excellence